Loading...
DOCUMENTS
22
NOTICES
36
MOTS CLES
Résistance
Gene expression
Inflammatory bowel disease
Neoadjuvant chemotherapy
Genes
Algorithm
Primary sclerosing cholangitis
Eradication
Anti-TNF agents
Parvimonas micra
Upper gastrointestinal tract
Méthylation
Colorectal cancer
COLON-CANCER
Alkylating agents
RISK
Rituximab plus chlorambucil
Venous thromboembolism
Biologics
Bactéries
Gene methylation
Crohn's disease
Resistance
Ulcerative colitis
DNA METHYLATION
Patient-reported outcome
Epigenetics
Consensus
IL12
Dysbiosis
Ustekinumab
Tuberculosis
Kidney diseases
Bacteria
Biomarker
Therapeutics
Contraindication
18 FDG-PET/CT
Stricture
Intestinal crypts
Clinical guidelines
MARKER
MICROBIOTA
Immune cells
Colon cancer
Heart disease risk factors
Eligibility
Disease progression
IL23
Dysbiose
Patients experience
Disability
Safety
Fecal microbiota
Epigénétiques
Cancer
Survival
Inflammatory Bowel Diseases
Rituximab
Inflammatory bowel diseases
Helicobacter pylori
Colon
Colectomy
IBD
Original Article Clinical
Crohn’s disease
Immunosuppressant
Gènes
Microbiote
Microbiota
Methylation
Screening
Cost effectiveness
MORTALITY
Colorectal cancer Colibactin and lipids
CARCINOGENESIS
Endoscopic treatment
Maintenance therapy
Cell adhesion
Over 80s
Vedolizumab
Inclusion
Surgery
PCR
DNA methylation
Drug
Acceptability
Inhibitor
Monitoring
HIV
Thérapie ciblée
Clinical trial
Disease Progression
Tailored therapy
Effectiveness
Colonic epithelial primary cells
Anti-TNF
MALT
T1118 translocation
Small molecules
Early detection of Colon Cancer using Molecular Markers and Microbiota , EA 7375 | |
---|---|
Institutions |
UPEC |
Adresse |
Université Paris-Est Créteil Groupe Hospitalier Henri Mondor Service de Gastroentérologie 51 Av Maréchal de Lattre de Tassigny 94010 Créteil cedex |
Courriel |
|
Site Internet |
|
Rattachement(s) |
|
Direction |
Aurélien AMIOT |
Adjoint |
Iradj SOBHANI |
Axe(s) de recherche
|
Le laboratoire axe ses recherches sur le rôle du microbiome intestinal ainsi que des changements épigénétiques dans l'intestin afin :
|
Derniers dépôts
-
Charlotte Gagniere, Anne Bourrier, Philippe Seksik, Jean-Marc Gornet, Olivier Dewit, et al.. Risk of serious infection in healthcare workers with inflammatory bowel disease: a case-control study of the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID). Alimentary Pharmacology & Therapeutics (Suppl), 2018, 48 (7), pp.713-722. ⟨10.1111/apt.14926⟩. ⟨hal-02013731⟩
-
Lucas Guillo, Mathieu Uzzan, Laurent Beaugerie, Jean-Marc Gornet, Aurélien Amiot, et al.. Impact of HIV Infection on the Course of Inflammatory Bowel Disease and Drug Safety Profile: A Multicenter GETAID Study. Clinical Gastroenterology and Hepatology, 2022, 20 (4), pp.787-797.e2. ⟨10.1016/j.cgh.2020.12.023⟩. ⟨hal-04168380⟩
-
Iradj Sobhani, Emma Bergsten, Cecile Charpy, Mathias Chamaillard, Denis Mestivier. Virulent Bacteria as Inflammatory and Immune Co-Factor in Colon Carcinogenesis: Evidence From Two Monozygotic Patients and Validation in CRC Patient and Healthy Cohorts. Frontiers in Cellular and Infection Microbiology, 2021, 11, pp.749750. ⟨10.3389/fcimb.2021.749750⟩. ⟨hal-04543208⟩
-
Lucas Guillo, Guillaume Savoye, Aurélien Amiot, Cyrielle Gilletta, Maria Nachury, et al.. Prevalence of and factors associated with extraintestinal manifestations and their remission in inflammatory bowel disease: the EXTRA prospective study from the GETAID. Clinical and translational gastroenterology, 2023, 14 (12), pp.e00607. ⟨10.14309/ctg.0000000000000607⟩. ⟨hal-04206330⟩
-
-
Florence Canouï-Poitrine, Astrid Lièvre, Florent Dayde, Daniel Lopez-Trabada-Ataz, Isabelle Baumgaertner, et al.. Inclusion of Older Patients with Cancer in Clinical Trials: The SAGE Prospective Multicenter Cohort Survey. Oncologist, 2019, 24 (12), pp.e1351-e1359. ⟨10.1634/theoncologist.2019-0166⟩. ⟨hal-04126614⟩
-
Maria Nachury, Yoram Bouhnik, Mélanie Serrero, Jerome Filippi, Xavier Roblin, et al.. Patients’ real-world experience with inflammatory bowel disease: A cross-sectional survey in tertiary care centres from the GETAID group. Digestive and Liver Disease, 2021, 53 (4), pp.434-441. ⟨10.1016/j.dld.2020.10.020⟩. ⟨hal-03038260⟩
-
-
Julien Tap, Aurélien Amiot, Véronique Jarrousse, Sandra Guilmeau, Jeanne Tran Vannhieu, et al.. Early Phenotypical Changes Induced By Transfer Of Human Fecal Microbiota from Colorectal Cancer Patients To Germ-Free Mice. International Journal of Cancer and Oncology, 2017, 4 (1), pp. 1-11. ⟨10.15436/2377-0902.16.1128⟩. ⟨hal-03825702⟩
-
Nicolas Petitdidier, Laurent Beaugerie, Franck Carbonnel, Anne Bourrier, Xavier Treton, et al.. Real-world use of therapeutic drug monitoring of CT-P13 in patients with inflammatory bowel disease: A 12-month prospective observational cohort study. Clinics and Research in Hepatology and Gastroenterology, 2020, 44, pp.609 - 618. ⟨10.1016/j.clinre.2019.11.008⟩. ⟨hal-03492351⟩